Abstract 5213: Drug repurposing to treat triple negative breast cancer (TNBC) based on a novel ER beta-p53-p73 signaling axis von Oturkar, Chetan C., Adams, Christina, Mukhopadhyay, Utpal K., Caradori, Alexander, Oshi, Manasori, Tokumaru, Yoshihisa, Creighton, Chad J., Park, Jun H., Gandhi, Nishant, Takabe, Kazuaki, Attwood, Kristopher M., Kaipparettu, Benny A., Das, Gokul M.

Volltext

Abstract 3986: Combination of tamoxifen and doxorubicin targets estrogen receptor beta-mutant p53-p73 axis: A novel therapeutic strategy for triple negative breast cancer von Das, Gokul M., Oturkar, Chetan C., Adams, Christina, Park, Jung H., Dolan, Melissa, Mastri, Michalis, Oshi, Manasori, Tokumaru, Yoshihisa, Mukhopadhyay, Utpal K., Abha, Kalyani, Jung, Kwang H., Yang, Sukjin, Kim, Suna, Ebos, John, Takabe, Kazuaki, Kaipparettu, Benny A.

Volltext